MIMETAS
2 known investors
MIMETAS develops Organ-on-a-Chip models that replicate human tissues and disease biology, powered by its OrganoPlate platform, to provide drug efficacy and safety data. It serves pharmaceutical and drug discovery teams working in immunology, infectious, metabolic, oncology, neurology, and ADME/tox research.
BiotechDeep TechHealthtech
Investors · 2
Frequently asked questions
- What does MIMETAS do?
- MIMETAS develops Organ-on-a-Chip models that replicate human tissues and disease biology, powered by its OrganoPlate platform, to provide drug efficacy and safety data. It serves pharmaceutical and drug discovery teams working in immunology, infectious, metabolic, oncology, neurology, and ADME/tox research.
- Who are MIMETAS's investors?
- MIMETAS's investors include KIKK Capital, Korys.